25 XP   0   0   10

Zhejiang Jiuzhou Pharm Co Ltd
Buy, Hold or Sell?

Let's analyse Zhejiang Jiuzhou Pharm Co Ltd together

PenkeI guess you are interested in Zhejiang Jiuzhou Pharm Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Zhejiang Jiuzhou Pharm Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Zhejiang Jiuzhou Pharm Co Ltd

I send you an email if I find something interesting about Zhejiang Jiuzhou Pharm Co Ltd.

Quick analysis of Zhejiang Jiuzhou Pharm Co Ltd (30 sec.)










What can you expect buying and holding a share of Zhejiang Jiuzhou Pharm Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.06
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥9.49
Expected worth in 1 year
¥13.00
How sure are you?
95.0%

+ What do you gain per year?

Total Gains per Share
¥3.94
Return On Investment
24.5%

For what price can you sell your share?

Current Price per Share
¥16.12
Expected price per share
¥14.56 - ¥21.08
How sure are you?
50%

1. Valuation of Zhejiang Jiuzhou Pharm Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥16.12

Intrinsic Value Per Share

¥3.60 - ¥4.17

Total Value Per Share

¥13.09 - ¥13.65

2. Growth of Zhejiang Jiuzhou Pharm Co Ltd (5 min.)




Is Zhejiang Jiuzhou Pharm Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$1.1b$701.2m$446.5m38.9%

How much money is Zhejiang Jiuzhou Pharm Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$35.6m$31.7m$3.8m10.9%
Net Profit Margin18.0%16.9%--

How much money comes from the company's main activities?

3. Financial Health of Zhejiang Jiuzhou Pharm Co Ltd (5 min.)




What can you expect buying and holding a share of Zhejiang Jiuzhou Pharm Co Ltd? (5 min.)

Welcome investor! Zhejiang Jiuzhou Pharm Co Ltd's management wants to use your money to grow the business. In return you get a share of Zhejiang Jiuzhou Pharm Co Ltd.

What can you expect buying and holding a share of Zhejiang Jiuzhou Pharm Co Ltd?

First you should know what it really means to hold a share of Zhejiang Jiuzhou Pharm Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Zhejiang Jiuzhou Pharm Co Ltd is ¥16.12. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Zhejiang Jiuzhou Pharm Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Zhejiang Jiuzhou Pharm Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥9.49. Based on the TTM, the Book Value Change Per Share is ¥0.88 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.22 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.11 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Zhejiang Jiuzhou Pharm Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.010.1%0.040.3%0.040.2%0.030.2%0.020.1%
Usd Book Value Change Per Share0.010.1%0.120.8%0.030.2%0.040.3%0.030.2%
Usd Dividend Per Share0.000.0%0.010.1%0.010.1%0.010.1%0.010.0%
Usd Total Gains Per Share0.010.1%0.140.8%0.040.2%0.050.3%0.040.3%
Usd Price Per Share3.34-3.93-6.28-4.51-3.93-
Price to Earnings Ratio81.89-35.19-45.71-56.90-978.25-
Price-to-Total Gains Ratio313.41--190.95-204.27-162.40-388.26-
Price to Book Ratio2.55-3.09-8.10-6.74-8.49-
Price-to-Total Gains Ratio313.41--190.95-204.27-162.40-388.26-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.226172
Number of shares449
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.01
Usd Book Value Change Per Share0.120.04
Usd Total Gains Per Share0.140.05
Gains per Quarter (449 shares)61.1523.94
Gains per Year (449 shares)244.6095.76
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
127218235167986
25343648033159182
38065472549238278
410787297066317374
51331090121582397470
61601308146098476566
718715261705115555662
821317441950131635758
924019622195148714854
1026721792440164793950

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%40.00.00.0100.0%
Book Value Change Per Share3.01.00.075.0%11.01.00.091.7%17.03.00.085.0%33.06.01.082.5%33.06.01.082.5%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%40.00.00.0100.0%
Total Gains per Share3.01.00.075.0%11.01.00.091.7%18.02.00.090.0%38.02.00.095.0%38.02.00.095.0%

Fundamentals of Zhejiang Jiuzhou Pharm Co Ltd

About Zhejiang Jiuzhou Pharm Co Ltd

Zhejiang Jiuzhou Pharmaceutical Co., Ltd manufactures and sells active pharmaceutical ingredients (API) and intermediates in China and internationally. Its API pipeline comprise central nervous system, non-steroidal, anti-infection, hypoglycemic and antiviral, tumor treatment, anti-depressant, Parkinson, HCV drugs, diabetes, cardiovascular, and respiratory anti-infection drugs. The company also provides asymmetric catalysts and lithium battery materials. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China.

Fundamental data was last updated by Penke on 2024-04-18 12:44:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Zhejiang Jiuzhou Pharm Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Zhejiang Jiuzhou Pharm Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Zhejiang Jiuzhou Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 7.0% means that ¥0.07 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Zhejiang Jiuzhou Pharm Co Ltd:

  • The MRQ is 7.0%. The company is making a profit. +1
  • The TTM is 18.0%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ7.0%TTM18.0%-10.9%
TTM18.0%YOY16.9%+1.1%
TTM18.0%5Y15.1%+2.9%
5Y15.1%10Y12.3%+2.8%
1.1.2. Return on Assets

Shows how efficient Zhejiang Jiuzhou Pharm Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Zhejiang Jiuzhou Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.6% Return on Assets means that Zhejiang Jiuzhou Pharm Co Ltd generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Zhejiang Jiuzhou Pharm Co Ltd:

  • The MRQ is 0.6%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 2.3%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ0.6%TTM2.3%-1.7%
TTM2.3%YOY2.9%-0.6%
TTM2.3%5Y2.2%+0.1%
5Y2.2%10Y1.8%+0.5%
1.1.3. Return on Equity

Shows how efficient Zhejiang Jiuzhou Pharm Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Zhejiang Jiuzhou Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.8% Return on Equity means Zhejiang Jiuzhou Pharm Co Ltd generated ¥0.01 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Zhejiang Jiuzhou Pharm Co Ltd:

  • The MRQ is 0.8%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.2%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.8%TTM3.2%-2.4%
TTM3.2%YOY4.6%-1.4%
TTM3.2%5Y3.4%-0.2%
5Y3.4%10Y2.7%+0.7%

1.2. Operating Efficiency of Zhejiang Jiuzhou Pharm Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Zhejiang Jiuzhou Pharm Co Ltd is operating .

  • Measures how much profit Zhejiang Jiuzhou Pharm Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Zhejiang Jiuzhou Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Zhejiang Jiuzhou Pharm Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM6.1%-6.1%
TTM6.1%YOY18.8%-12.8%
TTM6.1%5Y14.8%-8.8%
5Y14.8%10Y8.0%+6.8%
1.2.2. Operating Ratio

Measures how efficient Zhejiang Jiuzhou Pharm Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.60 means that the operating costs are ¥1.60 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Zhejiang Jiuzhou Pharm Co Ltd:

  • The MRQ is 1.604. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.419. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.604TTM1.419+0.185
TTM1.419YOY1.447-0.028
TTM1.4195Y1.457-0.038
5Y1.45710Y1.121+0.335

1.3. Liquidity of Zhejiang Jiuzhou Pharm Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Zhejiang Jiuzhou Pharm Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.81 means the company has ¥3.81 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Zhejiang Jiuzhou Pharm Co Ltd:

  • The MRQ is 3.812. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.113. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.812TTM3.113+0.699
TTM3.113YOY1.807+1.306
TTM3.1135Y2.197+0.915
5Y2.19710Y1.339+0.858
1.3.2. Quick Ratio

Measures if Zhejiang Jiuzhou Pharm Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Zhejiang Jiuzhou Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.58 means the company can pay off ¥0.58 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Zhejiang Jiuzhou Pharm Co Ltd:

  • The MRQ is 0.581. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.454. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.581TTM0.454+0.127
TTM0.454YOY0.353+0.101
TTM0.4545Y0.471-0.017
5Y0.47110Y0.554-0.083

1.4. Solvency of Zhejiang Jiuzhou Pharm Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Zhejiang Jiuzhou Pharm Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Zhejiang Jiuzhou Pharm Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.21 means that Zhejiang Jiuzhou Pharm Co Ltd assets are financed with 21.4% credit (debt) and the remaining percentage (100% - 21.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Zhejiang Jiuzhou Pharm Co Ltd:

  • The MRQ is 0.214. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.251. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.214TTM0.251-0.038
TTM0.251YOY0.350-0.098
TTM0.2515Y0.312-0.060
5Y0.31210Y0.270+0.042
1.4.2. Debt to Equity Ratio

Measures if Zhejiang Jiuzhou Pharm Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Zhejiang Jiuzhou Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 27.4% means that company has ¥0.27 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Zhejiang Jiuzhou Pharm Co Ltd:

  • The MRQ is 0.274. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.340. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.274TTM0.340-0.066
TTM0.340YOY0.546-0.205
TTM0.3405Y0.475-0.134
5Y0.47510Y0.407+0.067

2. Market Valuation of Zhejiang Jiuzhou Pharm Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Zhejiang Jiuzhou Pharm Co Ltd generates.

  • Above 15 is considered overpriced but always compare Zhejiang Jiuzhou Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 81.89 means the investor is paying ¥81.89 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Zhejiang Jiuzhou Pharm Co Ltd:

  • The EOD is 54.522. Based on the earnings, the company is expensive. -2
  • The MRQ is 81.885. Based on the earnings, the company is expensive. -2
  • The TTM is 35.193. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD54.522MRQ81.885-27.363
MRQ81.885TTM35.193+46.692
TTM35.193YOY45.711-10.518
TTM35.1935Y56.900-21.707
5Y56.90010Y978.249-921.348
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Zhejiang Jiuzhou Pharm Co Ltd:

  • The EOD is -35.299. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -53.014. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 24.346. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD-35.299MRQ-53.014+17.715
MRQ-53.014TTM24.346-77.359
TTM24.346YOY52.155-27.809
TTM24.3465Y36.396-12.050
5Y36.39610Y13.926+22.469
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Zhejiang Jiuzhou Pharm Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Zhejiang Jiuzhou Pharm Co Ltd:

  • The EOD is 1.699. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.552. Based on the equity, the company is underpriced. +1
  • The TTM is 3.087. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD1.699MRQ2.552-0.853
MRQ2.552TTM3.087-0.535
TTM3.087YOY8.096-5.009
TTM3.0875Y6.744-3.657
5Y6.74410Y8.491-1.747
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Zhejiang Jiuzhou Pharm Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0680.879-92%0.221-69%0.320-79%0.237-71%
Book Value Per Share--9.4879.240+3%5.645+68%5.214+82%3.802+149%
Current Ratio--3.8123.113+22%1.807+111%2.197+73%1.339+185%
Debt To Asset Ratio--0.2140.251-15%0.350-39%0.312-31%0.270-21%
Debt To Equity Ratio--0.2740.340-20%0.546-50%0.475-42%0.407-33%
Dividend Per Share--0.0090.107-91%0.067-86%0.066-86%0.055-83%
Eps--0.0740.304-76%0.256-71%0.182-59%0.112-34%
Free Cash Flow Per Share---0.1140.120-195%0.142-180%0.076-251%0.027-518%
Free Cash Flow To Equity Per Share---0.1140.230-150%0.066-273%0.114-200%0.102-212%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--4.168--------
Intrinsic Value_10Y_min--3.600--------
Intrinsic Value_1Y_max--0.391--------
Intrinsic Value_1Y_min--0.384--------
Intrinsic Value_3Y_max--1.195--------
Intrinsic Value_3Y_min--1.140--------
Intrinsic Value_5Y_max--2.023--------
Intrinsic Value_5Y_min--1.876--------
Market Cap14499714577.920-50%21776556447.36025602571993.320-15%40879390712.160-47%29343672809.544-26%25592959360.326-15%
Net Profit Margin--0.0700.180-61%0.169-58%0.151-53%0.123-43%
Operating Margin---0.061-100%0.188-100%0.148-100%0.080-100%
Operating Ratio--1.6041.419+13%1.447+11%1.457+10%1.121+43%
Pb Ratio1.699-50%2.5523.087-17%8.096-68%6.744-62%8.491-70%
Pe Ratio54.522-50%81.88535.193+133%45.711+79%56.900+44%978.249-92%
Price Per Share16.120-50%24.21028.463-15%45.448-47%32.623-26%28.453-15%
Price To Free Cash Flow Ratio-35.299+33%-53.01424.346-318%52.155-202%36.396-246%13.926-481%
Price To Total Gains Ratio208.684-50%313.414-190.953+161%204.274+53%162.397+93%388.264-19%
Quick Ratio--0.5810.454+28%0.353+65%0.471+23%0.554+5%
Return On Assets--0.0060.023-73%0.029-79%0.022-73%0.018-65%
Return On Equity--0.0080.032-75%0.046-83%0.034-77%0.027-71%
Total Gains Per Share--0.0770.986-92%0.288-73%0.386-80%0.292-74%
Usd Book Value--1178417090.3521147844963.329+3%701273602.495+68%647692981.407+82%472318179.132+149%
Usd Book Value Change Per Share--0.0090.121-92%0.030-69%0.044-79%0.033-71%
Usd Book Value Per Share--1.3101.276+3%0.780+68%0.720+82%0.525+149%
Usd Dividend Per Share--0.0010.015-91%0.009-86%0.009-86%0.008-83%
Usd Eps--0.0100.042-76%0.035-71%0.025-59%0.015-34%
Usd Free Cash Flow---14181959.81314876202.630-195%17676562.607-180%9383131.768-251%3389248.200-518%
Usd Free Cash Flow Per Share---0.0160.017-195%0.020-180%0.010-251%0.004-518%
Usd Free Cash Flow To Equity Per Share---0.0160.032-150%0.009-273%0.016-200%0.014-212%
Usd Market Cap2002410583.211-50%3007342445.3803535715192.277-15%5645443857.349-47%4052361214.998-26%3534387687.661-15%
Usd Price Per Share2.226-50%3.3433.931-15%6.276-47%4.505-26%3.929-15%
Usd Profit--9181584.46535673152.599-74%31794839.193-71%22140586.711-59%13658255.668-33%
Usd Revenue--130754289.756190696012.507-31%187992255.468-30%135999535.339-4%95521775.659+37%
Usd Total Gains Per Share--0.0110.136-92%0.040-73%0.053-80%0.040-74%
 EOD+3 -5MRQTTM+11 -24YOY+11 -245Y+11 -2410Y+12 -23

3.2. Fundamental Score

Let's check the fundamental score of Zhejiang Jiuzhou Pharm Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1554.522
Price to Book Ratio (EOD)Between0-11.699
Net Profit Margin (MRQ)Greater than00.070
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.581
Current Ratio (MRQ)Greater than13.812
Debt to Asset Ratio (MRQ)Less than10.214
Debt to Equity Ratio (MRQ)Less than10.274
Return on Equity (MRQ)Greater than0.150.008
Return on Assets (MRQ)Greater than0.050.006
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Zhejiang Jiuzhou Pharm Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.207
Ma 20Greater thanMa 5015.941
Ma 50Greater thanMa 10018.146
Ma 100Greater thanMa 20020.298
OpenGreater thanClose16.100
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets10,851,987
Total Liabilities2,318,916
Total Stockholder Equity8,461,133
 As reported
Total Liabilities 2,318,916
Total Stockholder Equity+ 8,461,133
Total Assets = 10,851,987

Assets

Total Assets10,851,987
Total Current Assets6,314,388
Long-term Assets4,537,599
Total Current Assets
Cash And Cash Equivalents 3,206,427
Net Receivables 962,281
Inventory 1,959,411
Other Current Assets 111,508
Total Current Assets  (as reported)6,314,388
Total Current Assets  (calculated)6,239,628
+/- 74,760
Long-term Assets
Property Plant Equipment 3,722,308
Goodwill 110,109
Intangible Assets 571,938
Long-term Assets Other 4,607
Long-term Assets  (as reported)4,537,599
Long-term Assets  (calculated)4,408,962
+/- 128,637

Liabilities & Shareholders' Equity

Total Current Liabilities1,656,620
Long-term Liabilities662,296
Total Stockholder Equity8,461,133
Total Current Liabilities
Accounts payable 1,197,601
Other Current Liabilities 7,020
Total Current Liabilities  (as reported)1,656,620
Total Current Liabilities  (calculated)1,204,621
+/- 451,999
Long-term Liabilities
Long term Debt 389,050
Capital Lease Obligations Min Short Term Debt11,895
Long-term Liabilities  (as reported)662,296
Long-term Liabilities  (calculated)400,945
+/- 261,352
Total Stockholder Equity
Retained Earnings 2,893,198
Total Stockholder Equity (as reported)8,461,133
Total Stockholder Equity (calculated)2,893,198
+/- 5,567,935
Other
Capital Stock899,486
Common Stock Shares Outstanding 899,486
Net Invested Capital 8,850,183
Net Working Capital 4,657,768
Property Plant and Equipment Gross 3,722,308



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312012-12-312011-12-31
> Total Assets 
1,113,579
1,343,338
1,551,016
0
1,798,969
2,660,046
2,208,231
2,172,631
2,799,483
2,740,242
3,335,224
3,313,058
2,971,153
3,019,509
2,998,807
3,113,923
3,114,965
3,157,465
3,142,512
3,379,050
3,218,092
3,189,607
3,304,910
3,339,287
3,223,590
3,606,702
4,670,281
4,995,377
5,063,256
4,863,964
5,001,794
5,685,476
6,169,338
6,452,384
7,040,424
7,545,719
7,928,191
7,839,932
7,913,276
10,954,904
11,335,876
11,294,589
10,851,987
10,851,98711,294,58911,335,87610,954,9047,913,2767,839,9327,928,1917,545,7197,040,4246,452,3846,169,3385,685,4765,001,7944,863,9645,063,2564,995,3774,670,2813,606,7023,223,5903,339,2873,304,9103,189,6073,218,0923,379,0503,142,5123,157,4653,114,9653,113,9232,998,8073,019,5092,971,1533,313,0583,335,2242,740,2422,799,4832,172,6312,208,2312,660,0461,798,96901,551,0161,343,3381,113,579
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,439,077
1,391,461
1,505,534
1,548,381
1,387,540
1,740,490
2,018,341
2,364,309
2,400,286
2,226,054
2,295,386
2,934,173
3,268,654
3,419,352
3,771,884
4,191,023
4,404,800
4,179,264
3,993,279
6,858,640
7,140,152
7,020,475
6,314,388
6,314,3887,020,4757,140,1526,858,6403,993,2794,179,2644,404,8004,191,0233,771,8843,419,3523,268,6542,934,1732,295,3862,226,0542,400,2862,364,3092,018,3411,740,4901,387,5401,548,3811,505,5341,391,4611,439,07700000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
425,162
308,884
276,111
370,412
229,725
586,393
565,153
941,078
714,539
614,763
324,572
751,539
932,184
988,534
1,120,801
1,589,216
1,548,544
1,495,711
1,095,426
4,030,842
4,154,225
3,918,776
3,206,427
3,206,4273,918,7764,154,2254,030,8421,095,4261,495,7111,548,5441,589,2161,120,801988,534932,184751,539324,572614,763714,539941,078565,153586,393229,725370,412276,111308,884425,16200000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30,000
712
70,000
0
0
0
0
12,746
27,454
7,707
30,679
20,839
26,064
27,091
1,060
0
0
0
0
0
0
0000001,06027,09126,06420,83930,6797,70727,45412,746000070,00071230,0000000000000000000000000
       Net Receivables 
143,612
187,857
165,303
0
259,210
240,252
301,960
210,738
283,190
270,073
248,515
241,337
312,823
380,034
418,538
350,625
346,249
361,151
362,727
495,524
462,005
374,814
624,308
367,566
373,262
402,462
574,272
412,279
569,010
439,409
699,767
779,005
797,865
903,868
855,739
753,963
1,078,629
767,596
671,108
825,455
1,072,876
1,101,670
962,281
962,2811,101,6701,072,876825,455671,108767,5961,078,629753,963855,739903,868797,865779,005699,767439,409569,010412,279574,272402,462373,262367,566624,308374,814462,005495,524362,727361,151346,249350,625418,538380,034312,823241,337248,515270,073283,190210,738301,960240,252259,2100165,303187,857143,612
       Other Current Assets 
27,341
38,021
41,541
0
36,411
46,349
73,954
233,571
72,870
64,988
49,310
511,612
41,613
55,667
25,824
30,237
13,714
26,310
28,543
33,134
28,973
146,337
40,153
85,066
95,036
37,277
51,029
94,101
87,129
102,783
73,690
81,377
78,338
80,631
87,383
83,125
82,524
86,071
55,153
64,715
119,670
62,843
111,508
111,50862,843119,67064,71555,15386,07182,52483,12587,38380,63178,33881,37773,690102,78387,12994,10151,02937,27795,03685,06640,153146,33728,97333,13428,54326,31013,71430,23725,82455,66741,613511,61249,31064,98872,870233,57173,95446,34936,411041,54138,02127,341
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,790,906
1,836,050
1,866,212
2,651,940
2,631,068
2,662,970
2,637,910
2,706,408
2,751,304
2,900,684
3,033,032
3,268,540
3,354,696
3,523,391
3,660,667
3,919,997
4,096,264
4,195,724
4,274,114
4,537,599
4,537,5994,274,1144,195,7244,096,2643,919,9973,660,6673,523,3913,354,6963,268,5403,033,0322,900,6842,751,3042,706,4082,637,9102,662,9702,631,0682,651,9401,866,2121,836,0501,790,90600000000000000000000000
       Property Plant Equipment 
527,250
646,013
752,616
0
870,697
909,929
960,469
981,384
1,519,274
1,552,428
1,578,441
1,589,744
1,603,968
1,593,412
1,604,155
1,590,444
1,573,843
1,553,915
1,526,526
1,505,364
1,499,820
1,512,719
1,522,007
1,520,368
1,567,488
1,595,299
2,237,546
2,219,693
2,243,848
2,261,048
2,321,426
2,337,056
2,373,204
2,436,538
2,645,070
2,683,850
2,762,496
2,904,626
3,144,271
3,227,160
3,362,188
3,439,273
3,722,308
3,722,3083,439,2733,362,1883,227,1603,144,2712,904,6262,762,4962,683,8502,645,0702,436,5382,373,2042,337,0562,321,4262,261,0482,243,8482,219,6932,237,5461,595,2991,567,4881,520,3681,522,0071,512,7191,499,8201,505,3641,526,5261,553,9151,573,8431,590,4441,604,1551,593,4121,603,9681,589,7441,578,4411,552,4281,519,274981,384960,469909,929870,6970752,616646,013527,250
       Goodwill 
0
0
0
0
0
0
0
0
5,957
5,957
6,670
6,670
6,670
6,670
6,670
6,670
6,670
6,670
6,670
6,670
6,670
6,670
0
0
0
0
75,073
75,073
75,073
75,073
75,073
75,073
75,073
75,073
70,352
97,050
107,242
107,242
111,111
110,849
110,586
110,348
110,109
110,109110,348110,586110,849111,111107,242107,24297,05070,35275,07375,07375,07375,07375,07375,07375,07375,07300006,6706,6706,6706,6706,6706,6706,6706,6706,6706,6706,6706,6705,9575,95700000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21,172
21,598
22,398
22,748
22,641
23,511
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000023,51122,64122,74822,39821,59821,17200000000000000000000
       Intangible Assets 
71,207
69,845
68,046
0
53,903
53,584
55,188
55,536
129,555
128,383
128,653
171,547
169,821
169,578
160,901
217,550
216,635
214,608
214,217
211,997
203,569
201,733
200,229
198,367
14,251
195,608
276,462
274,616
274,544
235,127
235,781
286,356
355,579
401,616
427,607
439,472
504,164
500,722
517,024
588,766
561,387
557,954
571,938
571,938557,954561,387588,766517,024500,722504,164439,472427,607401,616355,579286,356235,781235,127274,544274,616276,462195,60814,251198,367200,229201,733203,569211,997214,217214,608216,635217,550160,901169,578169,821171,547128,653128,383129,55555,53655,18853,58453,903068,04669,84571,207
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
53,456
52,513
41,970
35,027
36,251
35,308
2,295,413
36,537
12,593
11,650
10,707
12,152
11,209
10,266
9,323
8,380
7,437
6,494
5,551
4,607
4,6075,5516,4947,4378,3809,32310,26611,20912,15210,70711,65012,59336,5372,295,41335,30836,25135,02741,97052,51353,45600000000000000000000000
> Total Liabilities 
653,040
746,263
814,264
0
1,021,695
1,098,620
624,982
549,183
1,142,849
1,029,034
819,464
759,213
483,718
478,018
432,012
504,997
519,810
516,057
461,771
643,583
530,877
491,075
526,808
517,171
502,375
850,152
1,811,924
2,103,956
2,232,811
1,923,370
1,915,678
1,514,820
1,979,047
2,055,527
2,463,294
2,745,405
2,994,474
2,633,391
2,541,796
2,820,332
3,228,897
2,822,434
2,318,916
2,318,9162,822,4343,228,8972,820,3322,541,7962,633,3912,994,4742,745,4052,463,2942,055,5271,979,0471,514,8201,915,6781,923,3702,232,8112,103,9561,811,924850,152502,375517,171526,808491,075530,877643,583461,771516,057519,810504,997432,012478,018483,718759,213819,4641,029,0341,142,849549,183624,9821,098,6201,021,6950814,264746,263653,040
   > Total Current Liabilities 
525,992
617,673
694,389
0
822,628
867,150
578,550
505,309
1,024,153
932,157
743,183
691,456
421,922
424,614
397,928
467,835
474,670
472,858
407,956
591,329
468,809
425,445
458,600
449,733
433,641
751,423
1,192,021
1,485,466
1,636,552
1,382,907
1,633,041
1,373,714
1,825,465
1,894,307
2,084,701
2,364,166
2,554,748
2,168,435
2,213,993
2,396,631
2,734,875
2,217,349
1,656,620
1,656,6202,217,3492,734,8752,396,6312,213,9932,168,4352,554,7482,364,1662,084,7011,894,3071,825,4651,373,7141,633,0411,382,9071,636,5521,485,4661,192,021751,423433,641449,733458,600425,445468,809591,329407,956472,858474,670467,835397,928424,614421,922691,456743,183932,1571,024,153505,309578,550867,150822,6280694,389617,673525,992
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
77,135
80,000
353,179
341,090
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000341,090353,17980,00077,13500000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
77,135
80,000
353,179
341,090
504,791
581,519
623,780
788,016
501,806
556,301
697,687
498,836
670,673
466,554
203,578
50,050
401,433
610,490
591,148
0
0591,148610,490401,43350,050203,578466,554670,673498,836697,687556,301501,806788,016623,780581,519504,791341,090353,17980,00077,13500000000000000000000000
       Accounts payable 
224,019
261,513
285,172
0
370,210
404,844
341,887
378,364
416,637
428,886
412,593
373,251
310,286
315,889
231,311
304,744
300,192
315,119
261,007
238,170
233,947
222,137
281,641
268,209
254,386
267,433
349,320
369,515
399,112
567,919
530,254
590,671
766,921
860,116
988,141
1,122,790
1,195,901
1,216,359
1,245,037
1,097,989
1,099,268
1,072,659
1,197,601
1,197,6011,072,6591,099,2681,097,9891,245,0371,216,3591,195,9011,122,790988,141860,116766,921590,671530,254567,919399,112369,515349,320267,433254,386268,209281,641222,137233,947238,170261,007315,119300,192304,744231,311315,889310,286373,251412,593428,886416,637378,364341,887404,844370,2100285,172261,513224,019
       Other Current Liabilities 
42,440
49,389
60,351
0
40,629
50,543
126,069
41,234
62,276
55,303
65,590
53,205
61,742
73,626
153,713
66,215
99,667
120,854
117,229
129,836
84,814
111,788
78,554
72,927
54,961
95,940
367,096
527,092
488,806
120,063
154,943
227,052
405,971
223,530
428,662
469,277
704,198
562,475
506,465
4,358
644,558
8,297
7,020
7,0208,297644,5584,358506,465562,475704,198469,277428,662223,530405,971227,052154,943120,063488,806527,092367,09695,94054,96172,92778,554111,78884,814129,836117,229120,85499,66766,215153,71373,62661,74253,20565,59055,30362,27641,234126,06950,54340,629060,35149,38942,440
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
67,438
68,734
98,729
619,903
618,489
596,260
540,463
282,636
141,106
153,581
161,220
378,593
381,239
439,726
464,955
327,803
423,701
494,023
605,085
662,296
662,296605,085494,023423,701327,803464,955439,726381,239378,593161,220153,581141,106282,636540,463596,260618,489619,90398,72968,73467,43800000000000000000000000
       Other Liabilities 
0
28,167
38,301
0
36,067
31,160
36,432
33,759
29,276
81,376
27,943
26,890
28,127
27,033
30,794
33,872
45,140
43,199
53,815
51,781
62,069
65,630
68,208
67,438
68,734
98,729
129,204
127,266
125,863
129,934
142,443
141,106
152,232
159,870
173,863
174,953
194,798
212,748
0
0
287,010
0
0
00287,01000212,748194,798174,953173,863159,870152,232141,106142,443129,934125,863127,266129,20498,72968,73467,43868,20865,63062,06951,78153,81543,19945,14033,87230,79427,03328,12726,89027,94381,37629,27633,75936,43231,16036,067038,30128,1670
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
987
905
769
686
610
530
471
391
307
225
142
61
9,451
13,150
16,209
31,330
40,019
46,281
0
0
57,240
0
0
0057,2400046,28140,01931,33016,20913,1509,4516114222530739147153061068676990598700000000000000000000
> Total Stockholder Equity
456,757
592,591
732,595
736,752
771,985
1,556,821
1,580,840
1,621,362
1,656,634
1,711,208
2,515,760
2,553,845
2,487,435
2,534,959
2,560,106
2,602,355
2,588,927
2,635,512
2,675,104
2,730,477
2,682,270
2,693,711
2,773,578
2,818,100
2,717,431
2,752,626
2,854,626
2,887,792
2,826,942
2,937,260
3,083,208
4,170,632
4,190,283
4,396,849
4,577,130
4,791,857
4,853,799
5,128,440
5,296,559
8,060,888
8,032,465
8,399,569
8,461,133
8,461,1338,399,5698,032,4658,060,8885,296,5595,128,4404,853,7994,791,8574,577,1304,396,8494,190,2834,170,6323,083,2082,937,2602,826,9422,887,7922,854,6262,752,6262,717,4312,818,1002,773,5782,693,7112,682,2702,730,4772,675,1042,635,5122,588,9272,602,3552,560,1062,534,9592,487,4352,553,8452,515,7601,711,2081,656,6341,621,3621,580,8401,556,821771,985736,752732,595592,591456,757
   Common Stock
155,820
155,820
155,820
0
155,820
207,780
207,780
207,780
207,780
207,780
221,573
221,573
443,146
443,146
443,146
443,146
447,846
447,846
447,846
447,846
806,123
805,961
805,889
805,889
805,889
805,889
805,662
805,662
803,308
805,235
805,235
831,406
831,386
832,620
832,596
834,361
834,301
834,301
0
0
899,546
0
0
00899,54600834,301834,301834,361832,596832,620831,386831,406805,235805,235803,308805,662805,662805,889805,889805,889805,889805,961806,123447,846447,846447,846447,846443,146443,146443,146443,146221,573221,573207,780207,780207,780207,780207,780155,8200155,820155,820155,820
   Retained Earnings 
229,414
354,377
479,602
0
605,726
637,813
663,810
704,332
734,124
791,121
822,333
860,213
793,906
842,150
867,342
909,542
896,436
936,951
970,633
1,022,223
969,812
975,809
1,038,211
935,178
833,086
866,253
1,114,826
1,147,277
1,083,612
1,193,534
1,334,750
1,429,154
1,443,309
1,641,595
1,802,373
2,010,183
2,061,860
2,337,027
2,282,893
2,563,587
2,777,799
2,891,015
2,893,198
2,893,1982,891,0152,777,7992,563,5872,282,8932,337,0272,061,8602,010,1831,802,3731,641,5951,443,3091,429,1541,334,7501,193,5341,083,6121,147,2771,114,826866,253833,086935,1781,038,211975,809969,8121,022,223970,633936,951896,436909,542867,342842,150793,906860,213822,333791,121734,124704,332663,810637,813605,7260479,602354,377229,414
   Capital Surplus 0000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000-35,681-36,378-36,378-36,378-36,378-36,3780000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,996
6,573
6,474
5,926
5,709
6,098
3,299
4,015
3,181
2,547
2,538
1,104
1,286
1,295
1,487
2,240
2,835
8,354
0
0
13,658
0
0
0013,658008,3542,8352,2401,4871,2951,2861,1042,5382,5473,1814,0153,2996,0985,7095,9266,4746,5735,99600000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue5,523,418
Cost of Revenue-3,443,493
Gross Profit2,079,9252,079,925
 
Operating Income (+$)
Gross Profit2,079,925
Operating Expense-4,302,997
Operating Income1,220,421-2,223,073
 
Operating Expense (+$)
Research Development330,828
Selling General Administrative206,929
Selling And Marketing Expenses0
Operating Expense4,302,997537,757
 
Net Interest Income (+$)
Interest Income91,824
Interest Expense-21,734
Other Finance Cost-3,475
Net Interest Income66,616
 
Pretax Income (+$)
Operating Income1,220,421
Net Interest Income66,616
Other Non-Operating Income Expenses0
Income Before Tax (EBT)1,180,6421,220,421
EBIT - interestExpense = -21,734
1,033,256
1,054,989
Interest Expense21,734
Earnings Before Interest and Taxes (EBIT)01,202,376
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax1,180,642
Tax Provision-149,270
Net Income From Continuing Ops1,031,3721,031,372
Net Income1,033,256
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-66,616
 

Technical Analysis of Zhejiang Jiuzhou Pharm Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Zhejiang Jiuzhou Pharm Co Ltd. The general trend of Zhejiang Jiuzhou Pharm Co Ltd is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Zhejiang Jiuzhou Pharm Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Zhejiang Jiuzhou Pharm Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 18.76 < 20.79 < 21.08.

The bearish price targets are: 14.56.

Tweet this
Zhejiang Jiuzhou Pharm Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Zhejiang Jiuzhou Pharm Co Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Zhejiang Jiuzhou Pharm Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Zhejiang Jiuzhou Pharm Co Ltd. The current macd is -0.78414671.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Zhejiang Jiuzhou Pharm Co Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Zhejiang Jiuzhou Pharm Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Zhejiang Jiuzhou Pharm Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Zhejiang Jiuzhou Pharm Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartZhejiang Jiuzhou Pharm Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Zhejiang Jiuzhou Pharm Co Ltd. The current adx is 39.46.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Zhejiang Jiuzhou Pharm Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Zhejiang Jiuzhou Pharm Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Zhejiang Jiuzhou Pharm Co Ltd. The current sar is 14.70.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Zhejiang Jiuzhou Pharm Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Zhejiang Jiuzhou Pharm Co Ltd. The current rsi is 45.21. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Zhejiang Jiuzhou Pharm Co Ltd Daily Relative Strength Index (RSI) ChartZhejiang Jiuzhou Pharm Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Zhejiang Jiuzhou Pharm Co Ltd. The current phase is Overbought in bear market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Zhejiang Jiuzhou Pharm Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Zhejiang Jiuzhou Pharm Co Ltd Daily Stochastic Oscillator ChartZhejiang Jiuzhou Pharm Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Zhejiang Jiuzhou Pharm Co Ltd. The current cci is 11.88.

Zhejiang Jiuzhou Pharm Co Ltd Daily Commodity Channel Index (CCI) ChartZhejiang Jiuzhou Pharm Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Zhejiang Jiuzhou Pharm Co Ltd. The current cmo is 8.29414954.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Zhejiang Jiuzhou Pharm Co Ltd Daily Chande Momentum Oscillator (CMO) ChartZhejiang Jiuzhou Pharm Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Zhejiang Jiuzhou Pharm Co Ltd. The current willr is -14.75409836.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Zhejiang Jiuzhou Pharm Co Ltd Daily Williams %R ChartZhejiang Jiuzhou Pharm Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Zhejiang Jiuzhou Pharm Co Ltd.

Zhejiang Jiuzhou Pharm Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Zhejiang Jiuzhou Pharm Co Ltd. The current atr is 0.5899474.

Zhejiang Jiuzhou Pharm Co Ltd Daily Average True Range (ATR) ChartZhejiang Jiuzhou Pharm Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Zhejiang Jiuzhou Pharm Co Ltd. The current obv is -306,555,770.

Zhejiang Jiuzhou Pharm Co Ltd Daily On-Balance Volume (OBV) ChartZhejiang Jiuzhou Pharm Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Zhejiang Jiuzhou Pharm Co Ltd. The current mfi is 45.15.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Zhejiang Jiuzhou Pharm Co Ltd Daily Money Flow Index (MFI) ChartZhejiang Jiuzhou Pharm Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Zhejiang Jiuzhou Pharm Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-02BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-10MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-30WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside

6.3. Candlestick Patterns

Zhejiang Jiuzhou Pharm Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Zhejiang Jiuzhou Pharm Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.207
Ma 20Greater thanMa 5015.941
Ma 50Greater thanMa 10018.146
Ma 100Greater thanMa 20020.298
OpenGreater thanClose16.100
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Zhejiang Jiuzhou Pharm Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Zhejiang Jiuzhou Pharm Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Zhejiang Jiuzhou Pharm Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Zhejiang Jiuzhou Pharm Co Ltd

I send you an email if I find something interesting about Zhejiang Jiuzhou Pharm Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Zhejiang Jiuzhou Pharm Co Ltd.

Receive notifications about Zhejiang Jiuzhou Pharm Co Ltd in your mailbox!